DCOY is trading at $6.30 (12.4% down) as the stock extends a sharp pullback from its June 29 surge driven by a private placement financing of up to $21 million.
- Shares are retreating as investors lock in gains following the initial surge triggered by Decoy Therapeutics' funding announcement.
- Market sentiment is cooling as the stock corrects from the volatility seen immediately after the deal was disclosed.